Browse the evidence

Heterozygous loss of the mclk1 gene (mouse ortholog of clk-1) extends lifespan in mice by reducing oxidative stress and DNA damage, a mechanism evolutionarily conserved from nematodes.

This research highlights that genetic factors influencing oxidative stress and cellular fitness play a crucial role in longevity. While direct genetic manipulation is not a practical intervention for humans, the findings suggest that managing oxidative stress and supporting mitochondrial function (via ubiquinone/coenzyme Q pathways) may be important for healthy aging. Focus on lifestyle factors that support cellular health and reduce oxidative damage.

Optogenetic stimulation of LHA-LHb glutamatergic fibers produces an aversive behavioral phenotype, while inhibition produces a place preference.

Stimulating the neural pathway from the lateral hypothalamus to the lateral habenula is experienced as aversive by mice, while inhibiting it is experienced as rewarding. This suggests that this circuit normally suppresses the consumption of palatable foods, and its inhibition removes this suppression, leading to increased eating.

Central exposure to palmitic acid (a saturated fatty acid) induces hypothalamic insulin resistance by triggering the translocation and activation of the PKC-θ isoform, whereas oleic acid (a monounsaturated fatty acid) does not.

In the brain, saturated fats (specifically palmitic acid) disrupt insulin signaling by activating a specific enzyme (PKC-θ), leading to resistance. Monounsaturated fats (oleic acid) do not cause this disruption. This suggests that the type of fat matters significantly for brain metabolic health, not just the total amount.

Knocking down PKC-θ specifically in the hypothalamic arcuate nucleus protects against diet-induced obesity and improves insulin sensitivity in mice fed a high-fat, palmitic acid-enriched diet.

This finding suggests that the specific activation of PKC-θ in the brain is a key driver of obesity from high-fat diets. While not a direct human treatment, it highlights that targeting this specific pathway could potentially mitigate the metabolic damage of saturated fats.

Knocking down Ketohexokinase (KHK), the first enzyme in fructose metabolism, improves hepatic steatosis and glucose tolerance in fructose-supplemented mice.

This paper identifies Ketohexokinase (KHK) as a key enzyme in fructose metabolism. Inhibiting KHK in mice improved liver fat and glucose tolerance. While this suggests a potential future therapeutic target for fatty liver disease, the most immediate action for humans is to reduce fructose intake, especially with high-fat diets.

Knocking down hepatic Adipose Triglyceride Lipase (ATGL) causes hepatic steatosis by blocking triacylglycerol (TAG) hydrolysis and reducing fatty acid oxidation.

Your liver has a specific enzyme (ATGL) that breaks down stored fat. If this enzyme is suppressed, your liver stores more fat (steatosis) and burns less of it, even if you aren't eating excess calories. Maintaining healthy hepatic ATGL activity is crucial for preventing fatty liver and ensuring fatty acids are burned for energy rather than stored.

Chronic systemic administration of low-dose 2,4-dinitrophenol (DNP) acts as a caloric restriction mimetic by inducing mild mitochondrial uncoupling, which reduces oxidative stress, improves metabolic markers, and significantly extends lifespan in mice.

This research suggests that mild mitochondrial uncoupling can mimic the longevity and metabolic benefits of caloric restriction. In mice, low-dose DNP extended lifespan and improved metabolic health without reducing food intake. However, DNP is toxic at higher doses and is not approved for human use; this paper serves as a proof-of-concept for developing safer uncoupling agents rather than a recommendation for self-experimentation.

Semi-supercentenarians (aged 105+) exhibit a significantly lower epigenetic age (approx. 8.6 years younger) than expected based on their chronological age.

For individuals reaching extreme old age (105+), biological age may lag significantly behind chronological age. This suggests that some individuals possess genetic or epigenetic traits that slow down the molecular processes of aging. While this is not an intervention, it underscores the importance of biological age metrics in assessing health in the very elderly, as they may be biologically younger than their birth year suggests.

Occupational exposure to pesticides and biocides is associated with an increased risk of thyroid cancer, particularly in male adults.

Workers in agriculture or pest control should strictly adhere to safety protocols to minimize exposure to pesticides and biocides, as these chemicals are linked to an increased risk of thyroid cancer, particularly in men.

Consumption of branched-chain amino acids (BCAAs) alone does not stimulate muscle protein synthesis or produce an anabolic response in humans; instead, it decreases muscle protein synthesis and turnover.

Taking BCAAs by themselves will not build muscle or increase protein synthesis in humans. In fact, studies show it may actually slow down muscle protein turnover. To build muscle, you need a complete protein source containing all essential amino acids, not just BCAAs.

Common genetic variants in genes primarily influencing pancreatic beta-cell function (specifically ABCC8, KCNJ11, SLC2A2, HNF4A, and INS) significantly alter the risk of developing Type 2 diabetes.

If you have a family history of Type 2 diabetes, you likely carry genetic variants that affect how your pancreas secretes insulin or how your cells respond to it. This is not a life sentence, but it is a biological reality. You may need to be more vigilant with diet and exercise than someone without this genetic load to maintain healthy blood sugar levels, as your body may have less reserve in beta-cell function.

Enhanced PIP3 signaling in POMC neurons causes KATP channel activation, leading to neuronal silencing, hyperphagia, and diet-sensitive obesity.

This research highlights that obesity can stem from specific neural circuit failures (like POMC neuron silencing) rather than just caloric excess. While this is a mouse model, it suggests that interventions targeting hypothalamic signaling (like the PI3K pathway) might be necessary for certain types of diet-resistant or hyperphagic obesity, rather than just caloric restriction alone.

Prolonged elevation of free fatty acids (FFA) induces skeletal muscle insulin resistance by increasing flux through the hexosamine biosynthetic pathway, leading to the accumulation of UDP-N-acetyl-hexosamines (UDP-GlcNAc), which impairs glucose uptake and glycogen synthesis.

Chronic exposure to high levels of free fatty acids (from high-fat diets or obesity) can rewire how your muscles handle glucose, not just by burning less fat, but by triggering a specific metabolic pathway (hexosamine) that actively blocks insulin's ability to move glucose into cells. This block can persist even after you lower your fat intake, suggesting that long-term dietary habits have lasting metabolic consequences beyond immediate nutrient levels.

Healthcare professionals should assess biochemical hyperandrogenism using validated tandem mass spectrometry (LC-MS/MS) for testosterone, avoiding direct immunoassays due to their limited accuracy.

When getting blood work for PCOS, ensure your doctor orders testosterone testing via 'tandem mass spectrometry' (LC-MS/MS). This is the gold standard for accuracy. Avoid standard immunoassays if possible.

Pharmacological or genetic reduction of ceramide synthesis (e.g., via myriocin or CERS6 inhibition) reverses insulin resistance, diabetes, and cardiovascular complications in rodent models.

Research shows that blocking the production of ceramides in animals reverses diabetes and heart disease symptoms. While direct human trials with drugs like myriocin are not detailed here, this suggests that therapies targeting ceramide synthesis could be effective treatments for metabolic diseases in humans.

Myeloid-specific deletion of SIRT1 in macrophages induces hyperacetylation of the NF-kB RelA/p65 subunit, leading to chronic systemic inflammation, insulin resistance, and exacerbated obesity under high-fat dietary conditions.

Maintaining healthy metabolic function supports the activity of SIRT1, which helps regulate inflammation. While this study used genetic deletion in mice, it highlights that chronic inflammation and insulin resistance are linked to immune cell function. For humans, focusing on metabolic health through diet and exercise supports the natural regulatory pathways that SIRT1 is involved in, rather than relying on unproven supplements to target SIRT1 directly.

Dietary polyunsaturated fatty acids (PUFAs) suppress hepatic glycolytic and lipogenic gene expression (specifically L-PK and FAS) by inhibiting the nuclear translocation of the transcription factor ChREBP, a mechanism independent of AMPK activation.

Consuming polyunsaturated fats (like those found in fish oil, flaxseed, or sunflower oil) alongside carbohydrates can actively suppress the liver's genetic instructions to produce new fat and break down sugar for energy. This happens because PUFAs block the 'transport' of the key regulator (ChREBP) into the cell nucleus, preventing it from turning on fat-making genes. This specific effect is not seen with saturated fats (like butter) or monounsaturated fats (like olive oil).

The ventromedial nucleus of the hypothalamus acts as a 'satiety center' that inhibits the lateral 'feeding center'; destruction of this area causes hyperphagia and obesity due to a failure to terminate feeding, not an increase in the motivation to start eating.

If you struggle with stopping eating once you start, it may be a satiety signal issue rather than a craving issue. Focus on meal structure and stopping cues.

DHEA supplementation in healthy older adults does not improve well-being, cognition, or sexual function, and its decline with age does not necessarily cause these impairments.

If you are considering DHEA supplementation for anti-aging benefits, be aware that current evidence shows it does not improve well-being, cognition, or sexual function in healthy older adults. The decline in DHEA with age does not necessarily cause these impairments, and supplementation has not been proven to reverse them.

Earmarking (hypothecating) health tax revenues for specific health objectives increases public support for the tax and political sustainability, whereas using revenues for general fiscal purposes leaves the tax vulnerable to lobbying and repeal.

To ensure health taxes survive political pressure, governments must earmark the revenue for specific health-related spending, such as subsidizing healthy foods or targeting child obesity. This builds public support and protects the tax from industry lobbying that often leads to repeal when revenues go into the general fund.

Ectopic expression of PPARγ in non-adipogenic fibroblasts induces adipocyte differentiation and triggers a cascade expression of cyclin-dependent kinase inhibitors p18(INK4c) and p21(Waf1/Cip1), thereby coupling growth arrest with terminal differentiation.

This research explains the molecular basis of why fat cells (adipocytes) are stable once formed. It shows that the formation of fat cells is not random but is driven by specific genetic switches (PPARγ) that turn off cell division (via p18 and p21). While this doesn't offer a direct 'hack' for weight loss, it underscores that adipose tissue is a metabolically active, genetically regulated organ, not just inert storage, and that its formation is a permanent structural change at the cellular level.

Adiponectin levels do not differ between birth weight groups in middle-aged adults, suggesting adiponectin does not mediate the link between birth weight and obesity/diabetes risk.

Unlike leptin, adiponectin levels do not appear to be influenced by birth weight in middle-aged adults. Therefore, strategies to improve metabolic health should not focus on manipulating adiponectin levels based on birth weight history.

Abdominal obesity indices (CVAI, NC, WC, WHR, LAP, VAI) are not associated with the prevalence of diabetic retinopathy (DR) in diabetic adults, regardless of BMI adjustment.

Clinicians should not rely on abdominal obesity indices (like CVAI or Neck Circumference) to screen for diabetic retinopathy risk. Regular eye exams remain the gold standard for DR detection, as these body measurements do not correlate with retinal disease prevalence in diabetic patients.

HMB supplementation does not improve strength, body composition, or performance in experienced, resistance-trained athletes.

If you have been lifting consistently for years, HMB will not help you get stronger or build more muscle. Save your money.